We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

86 hedge funds and large institutions have $396M invested in Mirum Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 27 increasing their positions, 20 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 10

35% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 20

22% more call options, than puts

Call options by funds: $787K | Put options by funds: $643K

18% more funds holding

Funds holding: 73 → 86 (+13)

4.48% more ownership

Funds ownership: 76.5% → 80.98% (+4.5%)

15% less capital invested

Capital invested by funds: $465M → $396M (-$69.3M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
86
Holders Change
+13
Holders Change %
+17.81%
% of All Funds
1.32%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
24
Increased
27
Reduced
20
Closed
10
Calls
$787K
Puts
$643K
Net Calls
+$144K
Net Calls Change
-$350K

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$7.53M
2
ACM
AIGH Capital Management
Maryland
+$5.26M
3
SAM
Silvercrest Asset Management
New York
+$4.45M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$2.65M
5
BlackRock
BlackRock
New York
+$2.51M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$12.9M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.9M
3
Millennium Management
Millennium Management
New York
-$1.32M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$987K
5
AA
ALPS Advisors
Colorado
-$745K
Name Holding Trade Value Shares
Change 		Change in
Stake
IHAM
26
Integral Health Asset Management
New York
$1.59M +$1.56M +100,000 New
CIP
27
Chartwell Investment Partners
Pennsylvania
$1.46M +$394K +25,311 +38%
Northern Trust
28
Northern Trust
Illinois
$1.42M +$7.62K +490 +0.6%
WVP
29
Worth Venture Partners
New Jersey
$1.24M +$1.21M +77,515 New
Deutsche Bank
30
Deutsche Bank
Germany
$1.12M -$152K -9,755 -12%
PAM
31
Panagora Asset Management
Massachusetts
$1.07M +$607 +39 +0.1%
PAI
32
Palo Alto Investors
California
$1.03M +$1.01M +64,700 New
Prudential Financial
33
Prudential Financial
New Jersey
$1.02M +$996K +64,030 New
Marshall Wace
34
Marshall Wace
United Kingdom
$839K -$264K -16,982 -24%
ECM
35
ExodusPoint Capital Management
New York
$837K +$392K +25,221 +93%
Millennium Management
36
Millennium Management
New York
$763K -$1.32M -84,725 -64%
Invesco
37
Invesco
Georgia
$762K +$129K +8,319 +21%
Goldman Sachs
38
Goldman Sachs
New York
$658K +$642K +41,273 New
Russell Investments Group
39
Russell Investments Group
United Kingdom
$606K +$593K +38,092 New
Morgan Stanley
40
Morgan Stanley
New York
$477K +$294K +18,913 +172%
Renaissance Technologies
41
Renaissance Technologies
New York
$453K -$107K -6,900 -20%
Ohio Public Employees Retirement System (OPERS)
42
Ohio Public Employees Retirement System (OPERS)
Ohio
$418K +$222K +14,250 +119%
Connor, Clark & Lunn Investment Management (CC&L)
43
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$409K +$399K +25,618 New
RJFSA
44
Raymond James Financial Services Advisors
Florida
$404K +$24.5K +1,574 +7%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$385K +$5.45K +350 +1%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$382K -$987K -63,451 -73%
GCP
47
GSA Capital Partners
United Kingdom
$368K -$258K -16,607 -42%
JP Morgan Chase
48
JP Morgan Chase
New York
$360K +$40K +2,573 +13%
PP
49
PDT Partners
New York
$347K +$338K +21,750 New
Los Angeles Capital Management
50
Los Angeles Capital Management
California
$344K -$13K -835 -4%
1
2
3 4

MIRM Hedge Fund Activity: Q4 2021 in Review

86 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q4 2021, worth a combined $396M — down 15% from $465M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new MIRM positions and 10 closed out — a net gain of 14 holders — while 27 added to existing stakes and 20 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $7.53M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $12.9M sold.

  • 86 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q4 2021, up from 73 in Q3 2021.
  • Funds reported $396M of Mirum Pharmaceuticals stock for Q4 2021, down 15% quarter-over-quarter.
  • 24 funds opened new Mirum Pharmaceuticals positions in Q4 2021 and 10 closed out, a net change of +14 holders.
  • The largest Mirum Pharmaceuticals buyer in Q4 2021 was Franklin Resources, an estimated $7.53M added.
  • The largest Mirum Pharmaceuticals seller in Q4 2021 was Baker Bros. Advisors, an estimated $12.9M sold.

Based on aggregated 13F filings for Q4 2021.